Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No use in selling at .05 anyway. Better to hope for a miracle than take a 96% loss as opposed to a 99% at this point
“The Company believes that once it has completed the evaluation of the Study’s data, it could support further discussions with the FDA on potential new clinical studies and allow the opportunity to work with potential domestic and international pharmaceutical partners to determine a suitable regulatory pathway for approval of Bucillamine based on the evaluated Study’s data.”
This study is done and a wash apparently. Only way forward is a partner and new clinical trials for a “suitable regulatory pathway” which we all know how long will take. The fat lady has sung. How low does it go today? .2? .1? 0?
On good data would they be able to continue the study with new EP’s for FDA purposes while simultaneously marketing and selling it outside the US for immediate use in those countries that allow it?
Agreed. Continuing the study with hospitalizations as EP is lighting cash on fire and sacrificing time.
Continuation of the study is a death march.
Blue Cross Blue Shield no longer providing coverage for covid tests from providers. Day by day the outlook is more bleak. Why would they cover a drug for mild to moderate risk patients who have no chance of ending up in the hospital anymore? We’ll have to rely on out of pocket coverage?
The only way it moves up to .15 or beyond is announcement of a partnership or unblinding of data showing efficacy?
DMSB recommending continuing the study also maybe but we all know they don’t have the funding or time for that
They’re going to allow a film crew to document their ineptitude?
Bit of a word salad with multiple directions. Lets just hope they can deliver on SOMETHING
Thought the same. Utilized a PR to throw shade at BMT’s letter and request. Truly incredible
How in the F are you trying to still compare a tiny no revenue biotech penny stock firm to the Duponts and Apples of the world?!
So they’re using the capital raised to purchase MDMA stock and push that pipe dream forward. It should be 100% all Bucci focus right now
And then they have to start a new 3 year trial for the next virus?
That will be absolute murder
Id settle for a duplex at this point
You’re using a 3 year old post from Pumper Mike as your basis?! LOL
He’s threatening people that email him over on the reddit boards with his lawyer. Laughable CEO behavior
What kind of time table do you think this little company has with their limited resources to do all these things that you even admit takes BP years to complete Mike?
You want a 50-1 reverse stock split? How else do you imagine they avoid cash burn on the ~$3 million they have and the declare bankruptcy for BP to pick up for pennys?
You laid out next steps that could take years. A large long Covid study? 2 years? 3? It took that long for this study and then was when there were millions of subjects as possibilities
LOL No criticizing of an executive and company that has driven the stock price and shareholder wealth to all time lows.
Just shut up and do as told comrades.
And this perspective is why someone like MF who is out over his heels deserves criticism for not seeking out assistance. They brought in Biomedical Trader for consultation and then IGNORED his advice.
The orphan drug indication is a niche. They aren’t doing tens of thousands of these procedures a year.
Minimal revenues
Do you think 100 patients at high risk is sufficient for the FDA? Seems too small a sample size. Plus we know how slow revive moves. Getting to 1,000 could take them a year to enroll. “Time kills all deals”
Not to mention the cash burn.
All options were laid out by RVVTF in this press release. As you stated the only viable option at this point would be a BP buyout.
They do not have the resources to continue the study or start fresh. They never were able to get Turkey going. They weren’t even able to get to their target enrollment with the US/Turkey.
Their current and revised endpoints have been rejected by the FDA.
They admitted their study does NOT contain/meet the suggested endpoints from the FDA.
There is nothing left but bankruptcy. Dropping Bucci for covid and pivoting fully to shrooms or psychedelics which will be years of waiting for recovery of the SP.
Or
BP buyout.
Take $.10-20 cents and call it a day. Let the investors recoup some losses.
The market has spoken
Fake news? As in factual press releases FROM RVVTF
Exactly. Our only hope is letting BP step in. Their funding is mostly gone. They have no patients to continue a study with new EPs.
EcoMike touts the $3-$4 million they have from their latest offering as if you can fund a new trial or scramble to extend the current with everything that is needed to be done on that little sum of money.
Biomedical trader has been right every step of the way. I choose to trust him over Mikes claims of buying opportunities and market manipulation as the reason this thing may go to 2 cents in the next week.
The fat lady has sung
Yes and per your words in red this is done. You said it yourself. The only options here are to sell off to BP to try to salvage this or pivot to long covid which would likely need a new trial and years and millions of dollars in funding that they do not have. The fat lady has sung
Yes its all MM and shorts running down the SP of a pennystock with no revenue and a flailing phase III covid trial that they’ve tripled over themselves every step of the way. Can’t be that
Yes and the PR is a written response to the public regarding said written responses from the GDA where RVVTF said no thanks we will ignore and continue with previous end points which were already rejected by the FDA.
Hospitalizations and deaths are no longer a thing to 99%+ of the public with these weaker strains. Hence why FDA wants time to resolved symptoms.
Does this drug help people who get sick with covid get better faster yes or no? That’s it. Thats what the FDA wants to know. Not whether they will die.
The FDA is looking for essentially a stronger Dayquil for covid. Plain and simple.
Revive is ignoring that request apparently. Or the data doesn’t support it. That simple
LOL 20 cents?! This hasn’t seen 20 cents in six months. Now its going to .20 on this news?! Pump pump pump
Lotto ticket buys
LOL now you pivot to the orphan drug status and shrooms? You have no shame.
Let me guess you saw this all coming?
A lot of lawsuit talk on the reddit board. Even Biomedical Trader blamed management this morning as to the reason for this disaster.
I fear the sentiment is as it is over on the Reddit board and MF will drag this out as long as possible to collect his six figure salary.
As was stated over there we were told they would unblind the data regardless whether or not the FDA approved the end points. Now he claims they will not unblind the data.
This has all the markings of a scam at this point. Unfortunately I’ve been a part of these before on the OTC with fraudulent CEO’s milking it to the last drop
Dumbfounding. One would think after the first correction the FDA would say no we need XYZ. Very bizarre this vague back and forth. As stated either RVVTF is truly inept. Or the FDA is crooked. Both are believable IMO
Grifting 101
Give me a $1 a share and kick MF to the curb at this point
Delaying what seems to be a proven Japanese option till late ‘24. Similar to delaying a Canadian startup…FDA gonna FDA
It took 6 months to answer some questions and put together some data that they already have so lord knows how long this next submission will take
Here's a copy and paste from the May 16th 2022 PR:
"The Company has submitted a request to the FDA to determine and agree on the Study’s potential new primary efficacy endpoints, including the RATE of SUSTAINED clinical resolution of symptoms of COVID-19 which addresses the shift in COVID-19 clinical outcome observed over the course of the pandemic, and, therefore, to have more meaningful study endpoints for the FDA to consider for potential Emergency Use Authorization. The Company expects to obtain FDA agreement on the potential new primary efficacy endpoints in June 2023"
This is from a reddit comment. I haven't verified the claim from the old PR, but if so they've already submitted the rate of sustained resolution of symptoms to the FDA????? They already had this data yet claim they want it again?
This just buys BP much more time to swoop in with their own solution. A strategic kicking of the can down the road by the FDA. Yes I am bitter. And yes I hope I am proven wrong.
The study was not designed or approved for the relief of long covid. The timeline to compile or re-work and extend the existing trial will take a length of time that this company cannot afford. Literally. They are burning cash and that last raise won’t sustain a year plus of this.